UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO - Q3 2020 holdings

$96.1 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 24 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .

 Value Shares↓ Weighting
TSHA NewTAYSHA GENE THERAPIES INC$44,800,0002,000,000
+100.0%
46.63%
CSTL NewCASTLE BIOSCIENCES INC$12,632,000245,527
+100.0%
13.15%
IMTX NewIMMATICS NV$7,400,000697,431
+100.0%
7.70%
TFFP NewTFF PHARMACEUTICALS INC$4,076,000220,666
+100.0%
4.24%
CHRS NewCOHERUS BIOSCIENCES INC$753,00041,036
+100.0%
0.78%
PHR NewPHREESIA INC$493,00015,351
+100.0%
0.51%
IAU NewISHARES GOLD TRUSTinvestment funds, public markets-global equity$115,0006,400
+100.0%
0.12%
DIS NewWALT DISNEY CO/THE$99,000800
+100.0%
0.10%
HD NewHOME DEPOT INC/THE$97,000350
+100.0%
0.10%
ORCL NewORACLE CORPORATION$90,0001,503
+100.0%
0.09%
ACWI NewISHARES MSCI ACWI ETFinvestment funds, public markets-global equity$88,0001,106
+100.0%
0.09%
EW NewEDWARDS LIFESCIENCES CORP$67,000837
+100.0%
0.07%
SRE NewSEMPRA ENERGY$64,000537
+100.0%
0.07%
DHR NewDANAHER CORP$53,000245
+100.0%
0.06%
NKE NewNIKE INC$50,000400
+100.0%
0.05%
BRO NewBROWN & BROWN, INC$34,000753
+100.0%
0.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-06
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TEXAS INSTRUMENTS INC41Q3 202331.2%
PORTLAND GENERAL ELECTRIC CO38Q3 20230.0%
LEXICON PHARMACEUTICALS INC33Q3 20231.7%
AEGLEA BIOTHERAPEUTICS INC27Q2 202311.0%
APOLLO ENDOSURGERY INC24Q1 20235.6%
PLX PHARMA INC23Q1 20231.7%
VANGUARD MSCI EMERGING MKTS22Q2 201910.3%
VANGUARD ENERGY ETF22Q2 20198.7%
VANGUARD S&P 500 ETF21Q3 202311.8%
VANGUARD MSCI EAFE ETF20Q2 201913.1%

View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.

Latest significant ownerships (13-D/G)
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Taysha Gene Therapies, Inc.September 24, 20211,156,2553.0%
ZIOPHARM ONCOLOGY INCFebruary 12, 201690.0%

View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.

Latest filings
TypeFiled
42024-06-17
42024-06-12
42024-06-07
4/A2024-05-14
42024-05-01
32024-04-30
13F-HR2024-04-30
1442024-04-29
SC 13G2024-03-05
13F-HR2024-02-28

View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.

Compare quarters

Export UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's holdings